Oklahoma Patent of the Month – September 2024
General Genomics Inc. has made significant strides in predictive healthcare through its innovative method for assessing an organism’s susceptibility to medical conditions using advanced machine learning techniques. This approach begins with gathering a comprehensive dataset of attributes related to the living organism, which is then transformed into a feature vector. This vector serves as the foundation for the predictive analysis.
By employing one or more trained machine learning models, the system generates predictions regarding susceptibility to various medical conditions, including those related to respiratory complications caused by SARS-CoV-2. The models, trained on a featurized dataset from numerous historical cases, correlate medical histories with outcomes to assess risk accurately. This involves complex probabilistic calculations that estimate both the likelihood of the organism developing the condition and the historical prevalence among similar cases.
An intriguing aspect of this method is its dual-layered predictive mechanism. It integrates probability scores from multiple models, each weighted based on its relevance and accuracy. This not only enhances prediction reliability but also allows healthcare providers to tailor treatment recommendations effectively. For instance, if a high probability score aligns with a significant historical prevalence, clinicians can prioritize proactive interventions.
The feature generation process is meticulously designed to handle missing or incomplete data by substituting null values appropriately, ensuring robust analysis even in less-than-ideal data conditions. The implications of this technology are vast, offering a roadmap for improved patient care through early identification of risk factors and personalized treatment strategies. As General Genomics Inc. continues to refine this method, the potential to revolutionize predictive healthcare and enhance outcomes is both exciting and transformative.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.
Are you eligible?
Why choose us?
Pass an Audit?
What is the R&D Tax Credit?
The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.
Never miss a deadline again
Stay up to date on IRS processes
Discover R&D in your industry
R&D Tax Credit Preparation Services
Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.
If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.
R&D Tax Credit Audit Advisory Services
creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.
Our Fees
Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/
Choose your state
